Erythrocyte lifespan for predicting moderate and severe anemia in advanced gastric cancer patients post-anti-tumor therapeutics: a prospective study
This trial was retrospectively registered at China Clinical Trials Registry (ChiCTR2500097950) on February 27, 2025.
Authors
- Rongbo Lin (ORCID: https://orcid.org/0000-0002-6877-1691)
- Xianren Ye (ORCID: https://orcid.org/0000-0001-6103-0519)
- Xiurong Yu (ORCID: https://orcid.org/0000-0002-1311-6593)
- Liyu Su (ORCID: https://orcid.org/0000-0002-0076-9982)
- Rong Lu (ORCID: https://orcid.org/0000-0002-1905-9366)
- Shen Zhao
Institutions
- Fujian Medical University (CN)
- Fujian Provincial Cancer Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-11-19
- DOI
- https://doi.org/10.1186/s12885-025-15266-7
- Citations
- 1
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.05